Patents by Inventor Angelique Van 'T Wout

Angelique Van 'T Wout has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human antibodies binding to RSV G protein
    Patent number: 10196438
    Abstract: The disclosure relates to isolated antibodies and antigen-binding fragments that bind to the G protein of RSV and which are capable of neutralizing RSV A and B subtypes, and the use thereof in the diagnosis, prophylaxis, and/or treatment of RSV infections.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: February 5, 2019
    Assignee: Janssen Vaccines & Prevention B.V.
    Inventors: Jehangir Wadia, Robert Anthony Williamson, Johannes P. M. Langedijk, Gabriel Pascual, Angelique Van 'T Wout
  • Human antibodies binding to RSV G proteins
    Patent number: 10035842
    Abstract: The disclosure provides isolated antibodies and antigen-binding fragments that bind to the G protein of RSV and which are capable of neutralizing RSV.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: July 31, 2018
    Assignee: JANSSEN VACCINES & PREVENTION B.V.
    Inventors: Jehangir Wadia, Robert Anthony Williamson, Johannes P. M. Langedijk, Gabriel Pascual, Angelique Van 't Wout
  • HUMAN ANTIBODIES BINDING TO RSV G PROTEIN
    Publication number: 20160145321
    Abstract: The disclosure relates to isolated antibodies and antigen-binding fragments that bind to the G protein of RSV and which are capable of neutralizing RSV A and B subtypes, and the use thereof in the diagnosis, prophylaxis, and/or treatment of RSV infections.
    Type: Application
    Filed: April 14, 2014
    Publication date: May 26, 2016
    Applicant: CRUCELL HOLLAND B.V.
    Inventors: Jehangir Wadia, Robert Anthony Williamson, Johannes P.M. Langedijk, Gabriel Pascual, Angelique Van 'T Wout
  • HUMAN ANTIBODIES BINDING TO RSV G PROTEINS
    Publication number: 20160145322
    Abstract: The disclosure provides isolated antibodies and antigen-binding fragments that bind to the G protein of RSV and which are capable of neutralizing RSV.
    Type: Application
    Filed: April 14, 2014
    Publication date: May 26, 2016
    Applicant: CRUCELL HOLLAND B. V.
    Inventors: Jehangir Wadia, Robert Anthony Williamson, Johannes P.M. Langedijk, Gabriel Pascual, Angelique Van 't Wout